|Year : 2020 | Volume
| Issue : 3 | Page : 91
Editor's Page July 2020
Ravi R Kasliwal MD, DM, FIMSA, MNAMS, FASE
Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India
|Date of Web Publication||26-Sep-2020|
Dr. Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurgaon - 122 001, Haryana
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Kasliwal RR. Editor's Page July 2020. J Clin Prev Cardiol 2020;9:91
As I sit and write this Editor's page in a somber mood, I am reflecting on the last 150 days or so that have gone so quickly and yet have weighed so heavily on most individuals, in most nations of the globe. The pandemic has uprooted lives and livelihoods, brought economies crashing down, and wrought untold misery, disease, and death. However, the world just seems to go with the flow. The virulence of the virus must recede, and the hopes of the vaccine must accede. The virus cycle must break!
The first article “In-hospital and 1-year outcomes of octogenarian Indian patients with heart disease - Results from the Elder Heart Registry” from Kerala gives a very good and clear message that there is a requirement for looking after our octogenarian patients more seriously. People are living longer, and their total cardiac care should not be ignored. In this registry, the patients aged >80 years constituted almost 10% of the total coronary care admissions. Geriatric cardiology has been well addressed herein.
“Coronary artery disease among young drivers (<40 years) - Occupational hazard or air pollution driving it?” is a provocative article on young drivers and coronary artery disease. The authors have devised a Premature Coronary Artery Disease registry and meticulously studied both smokers and nonsmokers. This article is well articulated and needs a read.
“Plasma high-density lipoprotein cholesterol responses to endurance exercise training: a meta-analysis of randomized controlled trials” is a good article from Nepal and China and is a meta-analysis of randomized controlled trials, wherein the effects of endurance exercise of more than 8 weeks on lipid levels have been reported. The authors have specifically looked at high-density lipoprotein cholesterol levels, for which no safe and efficacious pharmacotherapy currently exists.
“Commemorating James Lind: the man who gave us the concept of controlled clinical trials” is an eye-opener on the life and times of James Lind who is credited for starting the concept of controlled clinical trials, though he never heard of the phrase himself, Amazing testimony to a scientific achiever!
This issue also includes three interesting case reports. “Hypotension in cath lab, a rare cause” is a well-written reminder to all of us who do procedures in the catheter laboratory that even common things can create serious issues. Awareness at all times is the key factor. “A rare case of Ebstein's anomaly with rheumatic mitral valve disease” is another carefully documented case report on the association of a rare congenital heart disease and an extremely common rheumatic heart disease. The message is to keep your eyes and mind open all the time while examining a patient and looking at their data. The final case report “Atrial myxoma with malignant appearance and dual arterial supply” from Australia describes another uncommon and interesting entity.
As the pandemic continues to rage across the world and mortality, in some areas, continues to increase, people keep their masks on, observe social distancing, and wash hands frequently, but everyone hopes to see the end of this disease and pray for an effective vaccine.
I do hope, dear Reader, that you have liked what we have put together for this issue of JCPC.